Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

REVIEW

Regulation of TLR expression, a new perspective for the role of VIP in immunity

R P Gomariz, A Arranz, Y Juarranz, I Gutierrez-Cañas, M Garcia-Gomez, J Leceta, C Martínez

Peptides 2007, 28 (9): 1825-32

The contribution of VIP immune functions to the regulation of homeostasis and health is well known. Modulation of immune responses through new therapeutics is one of the main goals of physicians and scientists seeking to control inflammatory/autoimmune diseases in humans. Initial therapeutic strategies targeted adaptive immune responses; discovery of Toll-like receptors (TLR) has widened the horizon to include targeting the innate immune system. In this review we have summarized recent information about VIP modulation of TLR function, and we suggest that VIP represents a new therapeutic option in the management of several pathologies.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Alicia Arranz, Yasmina Juarranz, Javier Leceta, Rosa P Gomariz, Carmen Martínez Peptides 2008, 29 (6): 948-56

Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. Rosa P Gomariz, Alicia Arranz, Catalina Abad, Marta Torroba, Carmen Martinez, Florencia Rosignoli, Maria Garcia-Gómez, Javier Leceta, Yasmina Juarranz Journal of Leukocyte Biology 2005, 78 (2): 491-502

The role of Toll-like receptors in immune disorders. Satoshi Uematsu, Shizuo Akira Expert Opinion on Biological Therapy 2006, 6 (3): 203-14

Therapeutic targeting of pattern-recognition receptors. Nima Rezaei International Immunopharmacology 2006, 6 (6): 863-9

Role of vasoactive intestinal peptide in inflammation and autoimmunity. Elena Gonzalez-Rey, Mario Delgado Current Opinion in Investigational Drugs 2005, 6 (11): 1116-23

[The role of Toll-like receptors in regulation of immune responses in norm and pathology]. N Ia Spivak, I M Bogdanova, N I Martirosova, V V Malaĭtsev Fiziolohichnyĭ Zhurnal 2008, 54 (6): 87-99

Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network. Yurii Chinenov, Inez Rogatsky Molecular and Cellular Endocrinology 2007 September 15, 275 (1): 30-42

Toll-like receptors and the eye. Alessandra Micera, Barbara Stampachiacchiere, Silvia Aronni, Myrna Serapiao dos Santos, Alessandro Lambiase Current Opinion in Allergy and Clinical Immunology 2005, 5 (5): 451-8

Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer. R E Roses, M Xu, G K Koski, B J Czerniecki Oncogene 2008 January 7, 27 (2): 200-7

TLR signaling. Taro Kawai, Shizuo Akira Seminars in Immunology 2007, 19 (1): 24-32

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Regulation of TLR expression, a new perspective for the role of VIP in immunity

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips